Related Experiment Videos
A novel epitope R7V common to all HIV-1 isolates is recognized by neutralizing IgG found in HIV-infected patients and
P Galéa1, C Le Contel, J C Chermann
1INSERM Unité 322-Unité de Recherche sur les Rétrovirus et Maladies associées, Université de la Méditerranée, Parc Scientifique et Technologique de Luminy, Marseilles, France.
Abstract:
We have previously reported that the presence of antibodies (Ab) directed to the beta2-microglobulin-derived peptide R7V in patient's serum correlated with the nonprogression to AIDS. In order to investigate whether R7V motif could represent a potential target for neutralization, we have immunopurified anti-R7V Ab from sera of nonprogressors, as well as from sera of rabbits injected with R7V. We showed that human as well as rabbit purified,anti-R7V IgG precipitated laboratory adapted strains, as well as primary isolates from different clades indicating that: (1) R7V epitope is a common motif presented at the surface of genetically divergent HIV-1 strains (2) R7V is immunogenic in vivo. When used in neutralizing assay, purified anti-R7V Ab from human or rabbit origin were shown to neutralize infection by HIV-1 laboratory adapted strains and HIV-1 primary isolates. All together, our results indicate that the R7V motif shared by all HIV strains could be considered as a possible candidate for an HIV vaccine.